Drug Trial Radar · NCT03925025
Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide Poisoning
Last checked: Nov 19, 2026Latest source record: Oct 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,728
Actual
Start
Jun 11, 2020
Primary completion
Mar 31, 2025
Study completion Apr 30, 2025
Sponsor
- Lead sponsor
- University of EdinburghAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Toxicology Society of Bangladesh
- First posted
- Apr 23, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates whether the addition of intravenous magnesium sulphate or nimodipine to standard therapy (supportive care plus for all patients atropine and, for OP insecticide poisoned patients, pralidoxime) benefits patients after acute anticholinesterase self-poisoning with OP or carbamate insecticides.
Conditions
- Anticholinesterase Insecticide Poisoning
- Pesticide Poisoning
Interventions
Magnesium SulfateDrug
Treatment in addition to standard therapy
NimodipineDrug
Treatment in addition to standard therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- MortalityTime frame: through to hospital discharge, median 1 week
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Chattogram Medical College Hospital
Chittagong, Bangladesh
Jashore Medical College Hospital
Jessore, Bangladesh
Khulna Medical College Hospital
Khulna, Bangladesh
Rangpur Medical College Hospital
Rangpur City, Bangladesh
Sylhet MAG Osmani Medical College Hospital
Sylhet, Bangladesh
Rajshahi Medical College Hospital
Rajshahi, Rajshahi Division, Bangladesh
Shaheed Ziaur Rahman Medical College
Bogura, Silimpur, Bangladesh
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.